| March 2013 | Price Indexes for Clinical Trial Research: A Feasibility Study
with Ernst R. Berndt, Iain M. Cockburn: w18918
|
| January 2012 | Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity
with Ajay K. Agrawal, Iain M. Cockburn, Alberto Galasso, Alexander Oettl: w17793
|
| May 2011 | Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D
with Iain M. Cockburn, Scott Stern, Jack Zausner
in Accelerating Energy Innovation: Insights from Multiple Sectors, Rebecca M. Henderson and Richard G. Newell, editors
|
| April 2011 | Comment on "The Confederacy of Software Production: Field Experimental Evidence on Heterogeneous Developers, Tastes for Institutions and Effort"
in The Rate and Direction of Inventive Activity Revisited, Josh Lerner and Scott Stern, editors
|
| August 2010 | Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research
with Jeffrey L. Furman, Margaret K. Kyle, Iain Cockburn, Rebecca M. Henderson
in Contributions in Memory of Zvi Griliches, Jacques Mairesse and Manuel Trajtenberg, editors
|
| February 2010 | The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions
with Iain M. Cockburn, Matthew J. Slaughter
in Innovation Policy and the Economy, Volume 10, Josh Lerner and Scott Stern, editors
|
| January 2010 | Not Invented Here? Innovation in Company Towns
with Ajay Agrawal, Iain Cockburn, Carlos Rosell
in Cities and Entrepreneurship, Edward Glaeser, Stuart Rosenthal and William Strange, organizers
|
| October 2009 | Not Invented Here? Innovation in Company Towns
with Ajay K. Agrawal, Iain M. Cockburn, Carlos Rosell: w15437
|
| November 2007 | Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry
with Iain M. Cockburn, Megan MacGarvie: w13644
|
| September 2007 | Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry
with Iain M. Cockburn, Megan J. MacGarvie
in Entrepreneurship: Strategy and Structure, Thomas Hellman and Scott Stern, editors
|
| June 2007 | Patents and the Survival of Internet-related IPOs
with Iain M. Cockburn, Stefan Wagner: w13146
|
| February 2007 | Is the Pharmaceutical Industry in a Productivity Crisis?
in Innovation Policy and the Economy, Volume 7, Adam B. Jaffe, Josh Lerner and Scott Stern, editors
|
| October 2006 | Entry and Patenting in the Software Industry
with Iain M. Cockburn, Megan J. MacGarvie: w12563
|
| September 2006 | Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
with Jeffrey L. Furman, Margaret K. Kyle, Iain M. Cockburn, Rebecca Henderson: w12509
|
| September 2004 | Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs
with Paul D. Chwelos, Ernst R. Berndt: w10746
|
| September 2003 | Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital
with Ajay Agrawal, Iain Cockburn, John McHale: w9950
|
| September 2002 | University Research, Industrial R&D, and the Anchor Tenant Hypothesis
with Ajay Agrawal, Iain M. Cockburn: w9212
|
| June 2002 | Are All Patent Examiners Equal? The Impact of Examiner Characteristics
with Iain M. Cockburn, Samuel Kortum, Scott Stern: w8980
|
| January 2001 | Publicly Funded Science and the Productivity of the Pharmaceutical Industry
with Iain M. Cockburn, Rebecca M. Henderson
in Innovation Policy and the Economy, Volume 1, Adam B. Jaffe, Josh Lerner and Scott Stern, editors
|
| Hedonic Analysis of Arthritis Drugs
with Iain M. Cockburn, Aslam H. Anis
in Medical Care Output and Productivity, David M. Cutler and Ernst R. Berndt, editors
|
| January 2000 | Do Patents Matter?: Empirical Evidence after GATT
with Jean O. Lanjouw, Iain Cockburn: w7495
|
| September 1999 | The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research
with Iain Cockburn, Rebecca Henderson, Scott Stern: w7359
|
| June 1999 | Public-Private Interaction and the Productivity of Pharmaceutical Research
with Iain Cockburn, Rebecca Henderson: w6018
|
| January 1999 | Balancing Incentives: The Tension Between Basic and Applied Research
with Iain Cockburn, Rebecca Henderson, Scott Stern: w6882
|
| May 1998 | Hedonic Analysis of Arthritis Drugs
with Iain M. Cockburn, Aslam H. Anis: w6574
|
| January 1998 | Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
with Ernst R. Berndt, Iain M. Cockburn, Douglas L. Cocks, Arnold M. Epstein, Zvi Griliches
in Frontiers in Health Policy Research, volume 1, Alan M. Garber, editor
|
| September 1997 | Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
with Ernst R. Berndt, Iain M. Cockburn, Douglas L. Cocks, Arnold Epstein, Zvi Griliches: w6182
|
| January 1995 | Generics and New Goods in Pharmaceutical Price Indexes
with Zvi Griliches, Iain Cockburn: w4272
|
| September 1993 | Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry
with Rebecca Henderson, Iain Cockburn: w4466
|
| October 1992 | Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers
with Iain Cockburn, Murray Frank: w4194
|
| December 1987 | Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents
with Iain Cockburn, Zvi Griliches: w2465
|
